1. Home
  2. KE vs DBVT Comparison

KE vs DBVT Comparison

Compare KE & DBVT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Kimball Electronics Inc.

KE

Kimball Electronics Inc.

HOLD

Current Price

$30.55

Market Cap

738.4M

Sector

Technology

ML Signal

HOLD

DBVT

DBV Technologies S.A.

HOLD

Current Price

$17.51

Market Cap

769.4M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
KE
DBVT
Founded
1961
2002
Country
United States
France
Employees
N/A
N/A
Industry
Electrical Products
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
738.4M
769.4M
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
KE
DBVT
Price
$30.55
$17.51
Analyst Decision
Strong Buy
Buy
Analyst Count
1
7
Target Price
$28.00
$31.75
AVG Volume (30 Days)
166.3K
575.0K
Earning Date
02-03-2026
10-28-2025
Dividend Yield
N/A
N/A
EPS Growth
91.88
N/A
EPS
0.96
N/A
Revenue
$1,478,074,000.00
$5,502,000.00
Revenue This Year
N/A
$1,768.71
Revenue Next Year
$4.71
$1,028.88
P/E Ratio
$31.13
N/A
Revenue Growth
N/A
N/A
52 Week Low
$12.41
$3.80
52 Week High
$33.19
$26.19

Technical Indicators

Market Signals
Indicator
KE
DBVT
Relative Strength Index (RSI) 60.75 49.16
Support Level $28.15 $16.69
Resistance Level $30.00 $18.40
Average True Range (ATR) 0.95 1.04
MACD 0.15 -0.37
Stochastic Oscillator 95.08 28.45

Price Performance

Historical Comparison
KE
DBVT

About KE Kimball Electronics Inc.

Kimball Electronics Inc is a contract electronic manufacturing services company. The company is engaged in producing durable electronics for the automotive, medical, industrial, and public safety end markets. The company's engineering, manufacturing, and supply chain services utilize common production and support capabilities. It is also engaged in producing safety-critical electronic assemblies for its automotive customers. Geographically, it has business units located in the United States, China, Mexico, Poland, Romania, and Thailand. The company derives maximum revenue from Mexico.

About DBVT DBV Technologies S.A.

DBV Technologies SA is a clinical-stage specialty biopharmaceutical company focused on changing the field of immunotherapy by developing a novel technology platform called Viaskin. The therapeutic approach is based on epicutaneous immunotherapy or EPIT, its proprietary method of delivering biologically active compounds to the immune system through intact skin using Viaskin, an epicutaneous patch (i.e., a skin patch). Its main product candidate under development is Viaskin Peanut for the treatment of peanut-allergic patients. In addition, the company also has earlier-stage food allergy programs, including Viaskin Milk and Eosinophilic Esophagitis, or EoE.

Share on Social Networks: